CN101991620A - Medicament prepared from okra extractive and application thereof - Google Patents
Medicament prepared from okra extractive and application thereof Download PDFInfo
- Publication number
- CN101991620A CN101991620A CN2009101124388A CN200910112438A CN101991620A CN 101991620 A CN101991620 A CN 101991620A CN 2009101124388 A CN2009101124388 A CN 2009101124388A CN 200910112438 A CN200910112438 A CN 200910112438A CN 101991620 A CN101991620 A CN 101991620A
- Authority
- CN
- China
- Prior art keywords
- abelmoschus esculentus
- application
- preparation
- medicine
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 241001075517 Abelmoschus Species 0.000 title abstract 6
- 238000002360 preparation method Methods 0.000 claims abstract description 23
- 229920001661 Chitosan Polymers 0.000 claims abstract description 3
- 201000001881 impotence Diseases 0.000 claims abstract description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 3
- 206010036596 premature ejaculation Diseases 0.000 claims abstract description 3
- 230000001954 sterilising effect Effects 0.000 claims abstract description 3
- 240000004507 Abelmoschus esculentus Species 0.000 claims description 42
- 235000003934 Abelmoschus esculentus Nutrition 0.000 claims description 42
- 239000000284 extract Substances 0.000 claims description 31
- 241000196324 Embryophyta Species 0.000 claims description 14
- 230000002265 prevention Effects 0.000 claims description 13
- 210000003097 mucus Anatomy 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 208000012895 Gastric disease Diseases 0.000 claims description 2
- 230000000747 cardiac effect Effects 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 208000018556 stomach disease Diseases 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 208000019622 heart disease Diseases 0.000 abstract description 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000004913 activation Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 241000628997 Flos Species 0.000 description 2
- 241000219071 Malvaceae Species 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000005739 manihot Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940027278 hetastarch Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament prepared from an okra extractive and application thereof. The medicament prepared from the okra extractive is prepared by the the following steps of; cleaning fresh okra picked within 6h, sterilizing, conveying into a squeezer and squeezing, separating by using a separator, taking out the okra grume extractive, and purifying the okra grume extractive with a 0.8-1.2% chitosan solution; and preparing into the medicament by adopting an excipient according to a conventional traditional China medicine preparation method. The medicament can be applied to medicines for treating or preventing male impotence, premature ejaculation, gastrosis, heart disease, apoplexia, osteoporosis, senile dementia and the like.
Description
Technical field
The present invention relates to medicament and application thereof with the Abelmoschus Esculentus Linn extract preparation.
Background technology
Abelmoschus esculentus, another name Flos abelmoschi manihot folder, swordweed are the annual herbaceous plant of Malvaceae.The Abelmoschus esculentus that we eat is its tender pod, and general length is that the middle finger length difference of 5-10 centimetre and hands is few, so its Abelmoschus esculentus, and another name Flos abelmoschi manihot folder, swordweed are the annual herbaceous plant of Malvaceae.Nutritional labeling: the tender pod of every 100g (or claiming fruit) contains protein 2.5g, fatty 0.1g, saccharide 2.7g, VA660 iu, VB10.2m g, VB20.06m g, VC44m g, calcium 81m g, phosphorus 63m g, ferrum 0.8m g.Abelmoschus esculentus surpasses 10 centimeters have been used with regard to anorexia, and behind the seed maturity, bakes and wear into fine powder, and its fragrance of distinguishing the flavor of reconstitutes dissolving soon, can make coffee surrogate, and is decaffeinated.
Discover the plant of a kind of mystery really of Abelmoschus esculentus through us, except tender folder was eaten as vegetable, it also had magical function.For this reason, we process extraction Abelmoschus esculentus effective ingredient and make medicament, are applied.
Summary of the invention
Discover Abelmoschus esculentus control nervus centralis safely and effectively through us, sexual organ's blood capillary, optimisation substance is the compound substance that Abelmoschus esculentus extracts, the extract that extracts from Abelmoschus esculentus is called " certain herbaceous plants with big flowers power is strong ", by water-soluble fibre pectin, composition such as galactan and Radix Acaciae senegalis, this complex can obviously add strong man's energy and energy and help and disperse dispirited spirit, can effectively stimulate male's sexual centre nerve, accelerate blood circulates and enhances metabolism, promote the microvascular activation of whole body organ, especially sexual organ's blood capillary, in addition can facilitating digestion, treatment gastritis, gastric ulcer can make because of the blood vessel blood supply insufficiency and cause: heart disease, apoplexy, skeleton bulking and Alzheimer etc. are able to real effectively prevention.The same men that to those readings of need cheering up, driving, maybe need to work through the night of the vigor effect of Abelmoschus esculentus have great help.If the complex that Abelmoschus esculentus extracts is made medicament, will make that its valid density is easier to be absorbed by the body.
One of purpose of the present invention is that a kind of medicament with the Abelmoschus Esculentus Linn extract preparation will be provided.
Two of purpose of the present invention is that a kind of application of using the medicament of Abelmoschus Esculentus Linn extract (certain herbaceous plants with big flowers power is strong) preparation will be provided.
Medicament with Abelmoschus Esculentus Linn extract (certain herbaceous plants with big flowers power is strong) preparation of the present invention, its preparation method is:
Though tender being clipped in of Abelmoschus esculentus can be preserved under the room temperature 3 days, its effect is unaffected, but in order to make the strong biological activity of certain herbaceous plants with big flowers power higher, on extracting, adopt the fresh Abelmoschus esculentus of plucking in 6 hours, clean, after the sterilization processing, after sending in the squeezer squeezing, separate, take out Abelmoschus esculentus mucus extract with seperator, use the 0.8-1.2% chitosan solution, Abelmoschus esculentus mucus extract is carried out purified treatment; Adopt known excipient of pharmaceutical field such as starch, hetastarch sodium, magnesium stearate etc. then, method of Chinese medicinal is routinely made the strong capsule of certain herbaceous plants with big flowers power, liquid preparation, powder, pill or tablet etc.
The strong capsule of 1 certain herbaceous plants with big flowers power of every production needs about 20 kilograms of fresh Abelmoschus esculentus as raw material,
The application of the medicament with Abelmoschus Esculentus Linn extract (certain herbaceous plants with big flowers power strong) preparation of the present invention is:
1. the application of Abelmoschus Esculentus Linn extract in the medicine for preparing treatment or prevention impotence, premature ejaculation;
2. the application of Abelmoschus Esculentus Linn extract in the medicine of preparation treatment or prevention gastropathy;
3. the application of Abelmoschus Esculentus Linn extract in the medicine of preparation treatment or prevention of cardiac;
4. the application of Abelmoschus Esculentus Linn extract in the medicine of preparation treatment or prevention of stroke;
5. the application of Abelmoschus Esculentus Linn extract in the medicine of preparation treatment or prevention skeleton bulking;
6. the application of Abelmoschus Esculentus Linn extract in preparation treatment or prevention Alzheimer's medicine;
Experiment confirm:
Abelmoschus Esculentus Linn extract of the present invention (certain herbaceous plants with big flowers power is strong) medicament makes by the effective absorbance of human body to reach 96%.
Effective ingredient in Abelmoschus Esculentus Linn extract of the present invention (certain herbaceous plants with big flowers power the is strong) medicament makes the oxygen delivery capacity of brain promote 5-7 doubly to the microvascular activation energy of brain.Make the people energetic.Clearheaded, guarantee that you are forced energetic all the time need stay up late or play with the life work the time.To the microvascular activation of muscle, can allow muscle that the absorption of nutrition and the release of creatine (rubbish of muscle discharging) are increased about 3 times, allow the people have inexhaustible energy up and down from head to foot.Microvascular activation allows skin absorb nutrition more easily equally and discharges toxin to skin.Can reduce cutis laxa, increase tight.Bring the young effect of unimaginable face.The most surprising to sexual centre nerve and the microvascular activation effect of male organ, directly cause the sexual centre nerve to become flourishing more, sexual organ's neural blood capillary is more intensive, and people's control force is advanced by leaps and bounds.The neural density of sexual centre of taking the most of man in back can increase 8%-10%, and sexual organ's blood capillary is active can to increase by 40%.(this never is same as common strengthening yang and invigorating kidney, in case the neural density of sexual centre increases enlarged areas).
The effect of Abelmoschus Esculentus Linn extract of the present invention (certain herbaceous plants with big flowers power is strong) medicament is very extensive in fact, to fatigue alleviating, reduces wrinkle (face's blood capillary fatigue) and acts on also clear ahead.Improve man's all undesirable conditions in sexual life comprehensively.
It is used to activate the effect of man's blood capillary and is described below: can feel obviously after taking that muscle power is full of vitality, endure and all do not think tired all night.2 wrinkles of skin reduce, and lax change is tight, and the people looks and shows young; Can promote male's control force, it is to be used to activate the microvascular product of man, can promote energy and muscle power synchronously comprehensively.The circulation of activation whole body blood capillary is acknowledged as the best approach that solves physical fatigue.
Now patient's case, the result with medicine of the present invention is exemplified below:
Chen Kaisheng, the man, 65 years old, people from Foochow, Fujian Province suffered from skeleton bulking through hospital diagnosis, took medicine of the present invention after 3 courses of treatment, cured rehabilitation.
Lin Zhixing, the man, 26 years old, live the Fujian Zhangpu County, through hospital diagnosis sexual impotence, premature ejaculation, take medicine of the present invention after 3 courses of treatment, cured in 2008.
Lin Yuying, the woman, 65 years old, people from Foshan through the hospital diagnosis Alzheimer, took medicine of the present invention after 3 courses of treatment, rehabilitation.
Chen Minghui, the man, 29 years old, live the Fujian Zhangpu County, suffer from premature ejaculation through hospital diagnosis, take medicine of the present invention after 3 courses of treatment, cure.
Wang Wenzhang, the man, 62 years old, people from Longhai City, Fujian suffered stroke through hospital diagnosis, took medicine of the present invention after 2 courses of treatment, cured rehabilitation.
The thin younger sister of Liu, the woman, 48 years old, people from ZhangZhou, Fujian suffered from gastric ulcer through hospital diagnosis, took medicine of the present invention after 2 courses of treatment, do not recur so far after curing in 2008.
He Juan, the woman, 46 years old, people from Chongqing, Sichuan through hospital diagnosis heart disease, took medicine of the present invention after 1 year, and check is cured.
Claims (7)
1. with the medicament of Abelmoschus Esculentus Linn extract preparation, it is characterized in that, described medicament its preparation method with the Abelmoschus Esculentus Linn extract preparation is: adopt the fresh Abelmoschus esculentus of plucking in 6 hours, clean, after the sterilization processing, send in the squeezer squeezing after, separate with seperator, take out Abelmoschus esculentus mucus extract, use the 0.8-1.2% chitosan solution, Abelmoschus esculentus mucus extract is carried out purified treatment; Adopt excipient then, method of Chinese medicinal is routinely made the strong capsule of certain herbaceous plants with big flowers power, liquid preparation, powder, pill or tablet.
2. the application of Abelmoschus Esculentus Linn extract in the medicine for preparing treatment or prevention impotence, premature ejaculation.
3. the application of Abelmoschus Esculentus Linn extract in the medicine of preparation treatment or prevention gastropathy.
4. the application of Abelmoschus Esculentus Linn extract in the medicine of preparation treatment or prevention of cardiac.
5. the application of Abelmoschus Esculentus Linn extract in the medicine of preparation treatment or prevention of stroke.
6. the application of Abelmoschus Esculentus Linn extract in the medicine of preparation treatment or prevention skeleton bulking.
7. the application of Abelmoschus Esculentus Linn extract in preparation treatment or prevention Alzheimer's medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101124388A CN101991620A (en) | 2009-08-28 | 2009-08-28 | Medicament prepared from okra extractive and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101124388A CN101991620A (en) | 2009-08-28 | 2009-08-28 | Medicament prepared from okra extractive and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101991620A true CN101991620A (en) | 2011-03-30 |
Family
ID=43782697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009101124388A Pending CN101991620A (en) | 2009-08-28 | 2009-08-28 | Medicament prepared from okra extractive and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101991620A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102370173A (en) * | 2011-10-10 | 2012-03-14 | 四川蓝田生物科技有限公司 | Okra healthcare food |
| CN103238798A (en) * | 2013-05-17 | 2013-08-14 | 绍兴儒林生物科技有限公司 | Dendrobium nutrient tablet and preparation method |
| CN104688788A (en) * | 2015-02-11 | 2015-06-10 | 杨先超 | Extraction method of okra mucilage |
| CN105381042A (en) * | 2015-12-03 | 2016-03-09 | 刘彩虹 | Traditional Chinese medicine composition for treating osteoporosis, preparation method and applications thereof |
| CN106074637A (en) * | 2016-08-19 | 2016-11-09 | 贾陆 | The preparation method and application of the Abelmoschus Esculentus Linn extract that a kind for the treatment of is suffered from a deficiency of the kidney |
| CN112043860A (en) * | 2020-09-11 | 2020-12-08 | 中国人民解放军陆军军医大学第二附属医院 | Biological adhesive material, preparation method and application thereof |
-
2009
- 2009-08-28 CN CN2009101124388A patent/CN101991620A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102370173A (en) * | 2011-10-10 | 2012-03-14 | 四川蓝田生物科技有限公司 | Okra healthcare food |
| CN103238798A (en) * | 2013-05-17 | 2013-08-14 | 绍兴儒林生物科技有限公司 | Dendrobium nutrient tablet and preparation method |
| CN103238798B (en) * | 2013-05-17 | 2015-04-22 | 绍兴儒林生物科技有限公司 | Dendrobium nutrient tablet and preparation method |
| CN104688788A (en) * | 2015-02-11 | 2015-06-10 | 杨先超 | Extraction method of okra mucilage |
| CN105381042A (en) * | 2015-12-03 | 2016-03-09 | 刘彩虹 | Traditional Chinese medicine composition for treating osteoporosis, preparation method and applications thereof |
| CN106074637A (en) * | 2016-08-19 | 2016-11-09 | 贾陆 | The preparation method and application of the Abelmoschus Esculentus Linn extract that a kind for the treatment of is suffered from a deficiency of the kidney |
| CN106074637B (en) * | 2016-08-19 | 2019-10-15 | 贾陆 | A kind of preparation method and application of Abelmoschus Esculentus Linn extract that treating kidney deficiency |
| CN112043860A (en) * | 2020-09-11 | 2020-12-08 | 中国人民解放军陆军军医大学第二附属医院 | Biological adhesive material, preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102048210B (en) | Red-date health protection beverage with function of alleviating fatigue | |
| CN101991620A (en) | Medicament prepared from okra extractive and application thereof | |
| CN103859375A (en) | Formula and preparation method of life cultivation and health preservation food helpful for enhancing immunity | |
| CN106418545A (en) | Functional food with balanced nutrients | |
| CN102669348B (en) | Nutrition food of heart nourishing tea granule for nourishing heart | |
| CN104825801A (en) | TCM (traditional Chinese medicine) preparation for preventing and treating cardiovascular and cerebrovascular diseases | |
| CN102742658B (en) | Goat milk tablet for maintaining beauty and keeping young and preparation method of goat milk tablet | |
| CN109699890A (en) | A kind of herbal formulation that can alleviate gout and high lithemia | |
| CN103908592A (en) | Traditional Chinese medicine for detoxification and preparation method of traditional Chinese medicine | |
| CN105211854B (en) | Honey refining ginseng grass is red | |
| CN105963359A (en) | Application of all-cannabinoid in preparation of drugs for treating depression | |
| CN109527577A (en) | A kind of composition with sobering up and liver protecting functions | |
| CN109730222A (en) | Ferment complex liquid and its health drink | |
| CN111184758B (en) | Composition containing caulis Mahoniae alcohol extract and cordycepin, preparation and application thereof | |
| CN108633997A (en) | A kind of healthcare goat milk powder and preparation method thereof with anti-fatigue effect | |
| CN102366458A (en) | Traditional Chinese medicine preparation for treating constipation caused by yin deficiency and preparation method thereof | |
| CN106720829A (en) | A kind of polygonatum Solomon's seal sugar-tablet and preparation method thereof | |
| CN101530210B (en) | Health preserving wine | |
| CN102133283A (en) | Medicine for treating constipation and preparation method thereof | |
| CN104286257A (en) | Poria cocos milk tea health-maintaining traditional Chinese medicine tea beverage and preparation method thereof | |
| CN102861223A (en) | Seven-medicament diabetes treating capsule | |
| CN115607635B (en) | Lucid ganoderma compound preparation and preparation method and application thereof | |
| CN1270733C (en) | Hunai Mushroom sclerotium used for treating diabotes and its preparation | |
| CN106620282A (en) | Herba dendrobii nobilis and American ginseng capsules and preparation method thereof | |
| CN102742655B (en) | Burdock goat milk tablet and preparation method of burdock goat milk tablet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Junlin Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Fuzhou Ruili Biotechnology Co., Ltd. Document name: Notification of before Expiration of Request of Examination as to Substance |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: FUZHOU KUILIJIAN BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: FUZHOU RUILI BIOTECHNOLOGY CO., LTD. Effective date: 20120816 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 350000 FUZHOU, FUJIAN PROVINCE TO: 350005 FUZHOU, FUJIAN PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20120816 Address after: 350005, Fujian City, Fuzhou province Wang Zhuang Street jewelry Road 2, Jewelry City Building 1, A District, 12 floor Applicant after: Fuzhou sunflower Biotechnology Co., Ltd. Address before: Gulou District of Fuzhou City, Fujian province 350000 East Road No. 150 Hengyu building B block 23 building 1906 room Applicant before: Fuzhou Ruili Biotechnology Co., Ltd. |
|
| DD01 | Delivery of document by public notice |
Addressee: Zhang Junlin Document name: Notification of Passing Examination on Formalities |
|
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110330 |
|
| WD01 | Invention patent application deemed withdrawn after publication |